# Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer

> **NCT01738815** · EARLY_PHASE1 · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 43 (actual)

## Conditions studied

- Hematuria
- Bladder Cancer

## Interventions

- **DRUG:** Valproic Acid

## Key facts

- **NCT ID:** NCT01738815
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2013-05
- **Final completion:** 2014-04
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01738815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01738815, "Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01738815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*